← Back to Search

Health Warning Labels for Vaping

N/A
Recruiting
Led By Noel Brewer, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 4 weeks
Awards & highlights

Study Summary

This trial tests the impact of e-cigarette warnings on vapers' intention to quit. US adult vapers are randomly assigned warnings (text/pictorial) to assess their reactions. 1,200 participants complete 3 visits.

Who is the study for?
This trial is for US adult vapers aged 21+ who use nicotine e-cigarettes regularly and can attend two in-person appointments, handle online surveys, and allow their devices to be labeled. Pregnant individuals or those in vaping studies cannot participate.Check my eligibility
What is being tested?
The study tests if warnings on e-cigarette devices affect users' intentions to quit. Participants will receive either text warnings, pictorial warnings, or neutral messages on their devices and refills to see the impact of these labels.See study design
What are the potential side effects?
Since this trial involves labeling rather than a physical intervention like medication or therapy, there are no direct side effects from the interventions being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean vaping quit intentions score
Secondary outcome measures
Mean attention score
Mean cognitive elaboration score
Mean inaccurate risk perception score
+13 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Label with text health warningExperimental Treatment1 Intervention
Labels with e-cigarette health warning that include text about health harms of vaping will be applied to participants' vaping devices and refills.
Group II: Label with pictorial health warningExperimental Treatment1 Intervention
Labels with e-cigarette health warning that include the same text about health harms of vaping and corresponding pictorial images will be applied to participants' vaping devices and refills.
Group III: Label with neutral statements about vapingExperimental Treatment1 Intervention
Labels with neutral statements about vaping will be applied to participants' vaping devices and refills.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,618,149 Total Patients Enrolled
10 Trials studying Vaping
5,072 Patients Enrolled for Vaping
University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,189,834 Total Patients Enrolled
1 Trials studying Vaping
3,840 Patients Enrolled for Vaping
Noel Brewer, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
3 Previous Clinical Trials
3,542 Total Patients Enrolled

Media Library

Label with neutral statements about vaping Clinical Trial Eligibility Overview. Trial Name: NCT05714982 — N/A
Vaping Research Study Groups: Label with neutral statements about vaping, Label with text health warning, Label with pictorial health warning
Vaping Clinical Trial 2023: Label with neutral statements about vaping Highlights & Side Effects. Trial Name: NCT05714982 — N/A
Label with neutral statements about vaping 2023 Treatment Timeline for Medical Study. Trial Name: NCT05714982 — N/A
Vaping Patient Testimony for trial: Trial Name: NCT05714982 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an open enrollment period for participants of this experiment?

"Affirmative. As per the clinicaltrials.gov record, this research is still attracting participants; it was first posted on February 1st 2023 and most recently amended two days later on February 2nd 2023."

Answered by AI

What sample size is the current trial utilizing?

"Affirmative. According to the data available on clinicaltrials.gov, this research endeavour is presently enlisting participants and was first posted on February 1st 2023. Approximately 1200 individuals are needed from one medical site."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Ewald & Wasserman Research Consultants, LLC
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Genuinely looking for any paid trials that I am qualified for.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Impact of E-cigarette Device Warnings
2023. "Impact of E-cigarette Device Warnings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05714982.
~600 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top